Biofire Defense recalls FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.
- Products
-
- FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative
- Company
- Biofire Defense
- Where it was sold
-
US Nationwide distribution in the states of AL, AZ, UT, CA, TX, DC , VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA.
States: Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Iowa, Kentucky, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Missouri, North Carolina, New Hampshire, Nevada, New York, Ohio, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington
- Barcodes
00851458005136- Units affected
- 130 Kits
- About this recall
- FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.